Skip to main content
. Author manuscript; available in PMC: 2020 Mar 28.
Published in final edited form as: Nanoscale. 2019 Mar 28;11(13):6192–6205. doi: 10.1039/c8nr08970a

Figure 9:

Figure 9:

Cell viability of brain tumor cell lines SJGBM2 (A), CHLA266 (B), CHLA200 (C) and U87 (D) exposed to C-dot-temo, C-dot-epi and C-dot-epi+temo. Data is presented as percent of non-treated control cells +/− SEM. #p<0.05 compared to control, *p<0.05 comparing C-dot-epi to C-dot-epi+temo.